tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Lee Lueder, 4 are a HOLD (30.77%), 9 are a BUY (69.23%).
Analyst Lee Lueder, currently employed carries an average stock price target met ratio of 86.11% that have a potential upside of 15.52% achieved within 82 days.
Lee Lueder’s has documented 26 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRL, Charles River Laboratories at 18-Dec-2023.
Analyst best performing recommendations are on IQV (IQVIA HOLDINGS).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 11/9/2023. The price target of $215 was fulfilled within 34 days with a profit of $45.53 (26.87%) receiving and performance score of 7.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$227
$35.86 (18.76%)
$203
1 months 6 days ago
(11-Nov-2024)
4/5 (80%)
$6.45 (2.92%)
44
Buy
$190
$-1.14 (-0.60%)
$190
2 months 10 days ago
(07-Oct-2024)
2/3 (66.67%)
$0.78 (0.41%)
8
Hold
$190
$-1.14 (-0.60%)
$191
2 months 27 days ago
(20-Sep-2024)
10/13 (76.92%)
$-15.79 (-7.67%)
73
Buy
$290
5 months 19 days ago
(28-Jun-2024)
5/7 (71.43%)
$27.87 (10.63%)
136
Buy
$265
$73.86 (38.64%)
10 months 2 days ago
(15-Feb-2024)
3/3 (100%)
$19.6 (7.99%)
114
What Year was the first public recommendation made by Lee Lueder?
